Hologic, Inc. (HOLX)
Last Price$63.3(0.2%)
Market Cap$14.7B
HOLX Rating
HOLX Quality rating performance
HOLX Intrinsic Value
Key Highlights:
As of Mar 03, 2025 HOLX Relative Value is $132.3, which is undervalued by 109.0%, compared to current share price of $63.3.
As of Mar 03, 2025 HOLX DCF Value is $131.6, which is undervalued by 107.9%, compared to current share price of $63.3.
HOLX Share Price History
1W (2.7%)
1M (11.8%)
6M (23.0%)
YTD (12.7%)
1Y (15.2%)
3Y (10.8%)
5Y 33.9%
10Y 94.3%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
HOLX Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$14.7B
$12.8B
$4,038.9M
$1,135.5M
Shares Outstanding
232M
Employees
N/A
Growth (CAGR)
3.6%
111.4%
27.88%
16.2%
27.10%
Profitability
56.2%
23.9%
18.4%
31.1%
28.1%
152.6%
Intrinsic Value
$131.7 (108.2% undervalued)
$132.4
$131.0
55.8%
Return on Capital
Financial Health
$1,972.7M
($1,925.9M)
(1.7x)
14.7x
Dividends
Earnings
Apr 30, 2025
BEAT by 1.0%
MISS by 0.0%
9 Beat & 1 Miss
HOLX Stock Financials
HOLX Income Statement Metrics
Annual
Quarterly
LTM
HOLX Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$1,285.2M +22.3% YoY
Capital Expenditure (CAPEX)
($140.2M) -6.7% YoY
Free Cash Flow (FCF)
$1,145.0M +27.1% YoY
HOLX Income Statement Overview
Annual
Quarterly
LTM
Sep'15
Sep'16
Sep'17
Sep'18
Sep'19
Sep'20
Sep'21
Sep'22
Sep'23
Sep'24
$4,030.3M (0.0%) YoY
Cost of revenue
$1,802.5M (8.0%) YoY
Pre-tax income
$865.1M 28.0% YoY
21.5% margin
HOLX Balance Sheet Overview
Annual
Quarterly
LTM
Sep'15
Sep'16
Sep'17
Sep'18
Sep'19
Sep'20
Sep'21
Sep'22
Sep'23
Sep'24
Assets
Liabilities
Total assets
$9,156.0M
Current assets ($3,823.3M, 41.8% of total)
$2,333.6M (25.5%)
$600.4M (6.6%)
Other current assets
$889.3M (9.7%)
Non-current assets ($5,332.7M, 58.2% of total)
$96.4M (1.1%)
$537.8M (5.9%)
$844.6M (9.2%)
Other non-current assets
$3,853.9M (42.1%)
Financial position
$324.4M
Cash & Short-term
Investments
Total Debt
HOLX Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
HOLX Earnings Surprises
Crunching data... Almost there!
HOLX Dividends
HOLX Dividend Yield
Crunching data... Almost there!
HOLX Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with HOLX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$14.7B | 7.3 | $131.7 108.2% undervalued | (15.2%) | $4,038.9M | $1,135.5M | 1.8% | 28.1% | 56.2% | 13.2% | 1.0% | |
$207.3B | 6.9 | $106.1 81.3% overvalued | 41.5% | $8,352.1M | $1,077.2M | 17.2% | 12.9% | 67.5% | 26.8% | 0.0% | |
$66.3B | 6.1 | $262.7 15.0% undervalued | (1.4%) | $20.6B | $2,936.0M | 5.9% | 14.2% | 59.4% | 5.4% | 55.9% | |
$46.6B | 6.4 | $81.3 13.6% overvalued | 9.9% | $9,926.1M | $608.0M | 3.6% | 6.1% | 55.6% | 9.1% | 23.8% | |
$34.6B | 7.6 | $190.6 18.2% overvalued | 29.9% | $4,926.8M | $1,388.4M | 12.9% | 28.2% | 57.9% | 32.9% | 16.0% | |
$18.6B | 5.8 | $92.7 1.2% undervalued | (10.8%) | $3,895.4M | $288.1M | 8.4% | 7.4% | 62.8% | 5.9% | 32.0% | |
$17.9B | 4.7 | $52.7 51.1% undervalued | (16.2%) | $12.9B | $566.0M | (14.0%) | 4.4% | 37.1% | (1.5%) | 191.5% | |
$16.9B | 6.1 | $152.8 33.0% overvalued | (36.3%) | $2,893.1M | $276.4M | (1.9%) | 9.6% | 34.6% | 18.6% | 11.3% | |
$10.4B | 5.2 | $139.9 26.6% overvalued | 50.3% | $2,094.4M | $145.3M | 2.3% | 6.9% | 48.0% | (14.8%) | 69.2% | |
$9,757.8M | 6.5 | $174.5 19.0% undervalued | 4.2% | $3,582.9M | $349.2M | 2.7% | 9.7% | 48.7% | 12.0% | 27.7% | |
$8,979.7M | 5.9 | $29.8 80.8% overvalued | (20.6%) | $616.0M | $131.3M | (8.0%) | 21.3% | 46.9% | (1.2%) | 33.3% |
FAQ
What is Hologic, Inc. (HOLX) stock rating?
As of today, Hologic, Inc. has a stock rating of 7 (out of 10), which is considered Great.
is Hologic, Inc. (HOLX) a good stock to buy?
As of today, Hologic, Inc. has a Great stock rating, which is 108.2% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.